NCT04163185Phase 3Completed

Initiating Early Control of Migraine Pain and Associated Symptoms

Study sponsor: Axsome Therapeutics, Inc. · AXSM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-03-16Actual
Enrollment · participants302Actual
Source updated2026-01-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 23 Mar 2020. After: 16 Mar 2020.

Check registry source